Fewer Side Effects, Better Quality of Life

Genitourinary cancers affect the reproductive organs and urinary system, which include the kidneys, ureters, bladder and urethra, as well as (in men) the prostate gland, testicles, penis and epididymis, and (in women) the uterus, fallopian tubes, ovaries, vagina, external genitalia and perineum. Treating genitourinary cancers with conventional radiation can lead to long-term urinary and reproductive problems. Proton therapy largely prevents these sensitive areas from receiving any measurable dose of excess radiation – making it ideal for a variety of genitourinary cancers including prostate cancer and uterine cancer.

Genitourinary Cancers We Treat Include
  • Prostate cancer
  • Kidney cancer (renal cell carcinoma)
  • Testicular cancer
  • Bladder (urothelial) cancer
  • Gynecologic cancers

Not All Proton Therapy Is Created Equal

Many other proton centers use “volumetric” beams that deliver a fixed quantity of energy to the entire tumor. But the pencil beam scanning technology at the New York Proton Center delivers “intensity-modulated proton therapy,” or IMPT.

Widely considered the most advanced form of proton therapy, IMPT can target different parts of the tumor with different radiation dose levels based on the prescription and tumor’s exact location, while better protecting the surrounding normal tissues from irradiation. That’s particularly valuable when treating the most complicated tumors.

Clinical Trials for Prostate Cancer

Learn about the available clinical trials for prostate cancer at the New York Proton Center.

Latest Articles